RxDoctor Payments Data

Aimee Lee, NP

Nurse Practitioner · Stanford, CANPI 1194900191

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (50.7%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. Medtronic accounts for 71.0% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2024 at $4,006 and has fallen 90.9% since, to $364 in 2025. Among nurse practitioner clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,727in general payments, 2019–2025

Across 50 payments — averaging $114.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$4K
  • Abbott$989
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$279
  • Biotronik Inc.$171
  • Kestra Medical Technology Services, Inc.$109
  • Boston Scientific$70
  • plus $41 from 1 others
$280in research payments, 2019–2025

Across 1 payment — averaging $280.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$280

What the payments were for

  • Consulting fees$3506%
  • Travel & lodging$2,90251%
  • Food & beverage$2,25439%
  • Education$2214%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,727 in reported general payments places this provider in the 95th percentile of 6,779 nurse practitioner providers in California.

See all nurse practitioner providers in California →

Medicare billing

Part B allowed, 2024
$16,262
Medicare patients
336
Services billed
377

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban14$12,682
Dofetilide44$7,787
Metoprolol Succinate17$193
SotalolSotalol Hcl22$191

Paid to pharmacies, not to this prescriber.

Other nurse practitioner in Stanford

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →